ES2586418T3 - Vacuna de proteína de fusión - Google Patents
Vacuna de proteína de fusión Download PDFInfo
- Publication number
- ES2586418T3 ES2586418T3 ES08724181.6T ES08724181T ES2586418T3 ES 2586418 T3 ES2586418 T3 ES 2586418T3 ES 08724181 T ES08724181 T ES 08724181T ES 2586418 T3 ES2586418 T3 ES 2586418T3
- Authority
- ES
- Spain
- Prior art keywords
- amino acid
- fusion protein
- acid sequence
- protein vaccine
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108020001507 fusion proteins Proteins 0.000 title abstract 3
- 229940023143 protein vaccine Drugs 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 6
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 241000193990 Streptococcus sp. 'group B' Species 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Una proteína de fusión que comprende al menos dos secuencias de aminoácidos, donde dichas dos secuencias de aminoácidos consisten en una primera secuencia de aminoácidos que tiene al menos el 90% de identidad de secuencia con una secuencia de aminoácidos tal como se muestra en la SEQ ID NO: 2, fusionada con una segunda secuencia de aminoácidos que tiene al menos el 90% de identidad de secuencia con una secuencia de aminoácidos tal como se muestra en la SEQ ID NO: 4, donde dicha proteína de fusión es capaz de conferir inmunidad protectora contra el estreptococo del grupo B.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0700919 | 2007-04-16 | ||
SE0700919 | 2007-04-16 | ||
US94047307P | 2007-05-29 | 2007-05-29 | |
US940473P | 2007-05-29 | ||
PCT/SE2008/000270 WO2008127179A1 (en) | 2007-04-16 | 2008-04-14 | Fusion protein vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2586418T3 true ES2586418T3 (es) | 2016-10-14 |
Family
ID=39864173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES08724181.6T Active ES2586418T3 (es) | 2007-04-16 | 2008-04-14 | Vacuna de proteína de fusión |
Country Status (15)
Country | Link |
---|---|
US (1) | US8313748B2 (es) |
EP (1) | EP2144924B1 (es) |
CN (1) | CN101855238B (es) |
CA (1) | CA2684494C (es) |
CY (1) | CY1117896T1 (es) |
DK (1) | DK2144924T3 (es) |
ES (1) | ES2586418T3 (es) |
HR (1) | HRP20160995T1 (es) |
HU (1) | HUE028253T2 (es) |
LT (1) | LT2144924T (es) |
PL (1) | PL2144924T3 (es) |
PT (1) | PT2144924T (es) |
RU (1) | RU2487890C2 (es) |
SI (1) | SI2144924T1 (es) |
WO (1) | WO2008127179A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014018904A1 (en) * | 2012-07-26 | 2014-01-30 | Genocea Biosciences, Inc. | Fused antigen vaccines and compositions against streptococcus pneumoniae |
ES2848048T3 (es) | 2012-10-03 | 2021-08-05 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas |
CN103694323B (zh) * | 2013-12-09 | 2017-01-18 | 成都欧林生物科技股份有限公司 | 金黄色葡萄球菌MntC重组蛋白及其制备方法和应用 |
EP3365003A1 (en) | 2015-10-21 | 2018-08-29 | Minervax APS | Immunogenic fusion protein |
US10888610B2 (en) * | 2015-12-30 | 2021-01-12 | Minerv Ax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
CA3066020A1 (en) | 2017-06-16 | 2018-12-20 | Glaxosmithkline Biologicals Sa | Method of treatment |
CN114728051A (zh) | 2019-11-22 | 2022-07-08 | 葛兰素史克生物有限公司 | 细菌糖糖缀合物疫苗的剂量和施用 |
WO2021250626A2 (en) | 2020-06-12 | 2021-12-16 | Glaxosmithkline Biologicals Sa | Dock tag system |
WO2021250625A2 (en) | 2020-06-12 | 2021-12-16 | Glaxosmithkline Biologicals Sa | Gbs ferritin nanoparticles |
EP4066854A1 (en) | 2021-03-29 | 2022-10-05 | MinervaX | Immunogenic fusion protein |
CN114437235B (zh) * | 2022-01-04 | 2024-02-09 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 |
CN116478953B (zh) * | 2023-06-14 | 2023-09-12 | 四川大学华西医院 | 鲍曼不动杆菌DlaT重组蛋白、制备方法及应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4225579A (en) * | 1979-02-27 | 1980-09-30 | Israel Kleinberg | Means and method for improving defenses against caries |
US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
US4879213A (en) * | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
WO1994001031A1 (fr) | 1992-07-02 | 1994-01-20 | Paul Charvet | Appareil de cuisson dans l'huile a chauffage au gaz |
ATE214601T1 (de) * | 1992-09-16 | 2002-04-15 | Univ Tennessee Res Corp | Rekombinantes vielwertiges m-protein-vakzin |
IL107458A0 (en) | 1992-11-02 | 1994-02-27 | Gen Hospital Corp | Conjugate vaccine against group b streptococcus |
DE69432658T2 (de) * | 1993-03-19 | 2004-04-08 | Gunnar Lindahl | Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei) |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US6426074B1 (en) | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
GB9808932D0 (en) * | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
EP1601689B1 (en) * | 2003-03-13 | 2007-11-28 | GlaxoSmithKline Biologicals S.A. | Purification process for bacterial cytolysin |
CA2537742C (en) * | 2003-09-15 | 2014-07-22 | Chiron Corporation | Immunogenic compositions for streptococcus agalactiae |
-
2008
- 2008-04-14 EP EP08724181.6A patent/EP2144924B1/en active Active
- 2008-04-14 PL PL08724181T patent/PL2144924T3/pl unknown
- 2008-04-14 CA CA2684494A patent/CA2684494C/en active Active
- 2008-04-14 RU RU2009142976/10A patent/RU2487890C2/ru active
- 2008-04-14 US US12/596,249 patent/US8313748B2/en active Active
- 2008-04-14 DK DK08724181.6T patent/DK2144924T3/en active
- 2008-04-14 LT LTEP08724181.6T patent/LT2144924T/lt unknown
- 2008-04-14 SI SI200831661A patent/SI2144924T1/sl unknown
- 2008-04-14 CN CN200880020390.1A patent/CN101855238B/zh active Active
- 2008-04-14 HU HUE08724181A patent/HUE028253T2/en unknown
- 2008-04-14 PT PT87241816T patent/PT2144924T/pt unknown
- 2008-04-14 WO PCT/SE2008/000270 patent/WO2008127179A1/en active Application Filing
- 2008-04-14 ES ES08724181.6T patent/ES2586418T3/es active Active
-
2016
- 2016-08-08 HR HRP20160995TT patent/HRP20160995T1/hr unknown
- 2016-08-09 CY CY20161100783T patent/CY1117896T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL2144924T3 (pl) | 2017-06-30 |
RU2009142976A (ru) | 2011-05-27 |
WO2008127179A8 (en) | 2009-07-23 |
HUE028253T2 (en) | 2017-02-28 |
RU2487890C2 (ru) | 2013-07-20 |
EP2144924A1 (en) | 2010-01-20 |
SI2144924T1 (sl) | 2016-12-30 |
WO2008127179A1 (en) | 2008-10-23 |
CY1117896T1 (el) | 2017-05-17 |
CN101855238A (zh) | 2010-10-06 |
CA2684494A1 (en) | 2008-10-23 |
HRP20160995T1 (hr) | 2016-10-21 |
DK2144924T3 (en) | 2016-08-22 |
PT2144924T (pt) | 2016-08-17 |
LT2144924T (lt) | 2016-10-10 |
EP2144924A4 (en) | 2010-08-25 |
CA2684494C (en) | 2016-07-05 |
CN101855238B (zh) | 2014-09-17 |
US20100062015A1 (en) | 2010-03-11 |
US8313748B2 (en) | 2012-11-20 |
EP2144924B1 (en) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2586418T3 (es) | Vacuna de proteína de fusión | |
ES2513716T3 (es) | Enzimas lecitina-colesteros acitransferasa modificadas | |
ES2652643T3 (es) | Péptidos terapéuticos y su uso contra la corea de Huntington | |
JP2013172734A5 (es) | ||
EA201270517A1 (ru) | Микобактериальные вакцины | |
ES2722799T3 (es) | Vacunas contra el cáncer de cerebro basadas en el péptido alfa 2 del receptor de interleuquina-13 | |
AR090469A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
EA201000327A1 (ru) | Белок | |
ES2694667T3 (es) | Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato | |
ES2666720T3 (es) | Composición para prevenir o tratar el cáncer de cuello uterino con un potenciador de la inmunidad contra el virus de papiloma humano | |
ES2531115T3 (es) | Combinaciones de clados de RrgB neumocócicos | |
PE20081723A1 (es) | Vacuna contra el papilomavirus | |
ES2627117T3 (es) | Método basado en MGMT para obtener un rendimiento elevado de expresión de proteínas recombinantes | |
UY36920A (es) | Formulaciones de aminoácidos de liberación modificada administradas por vía oral | |
ES2627330T3 (es) | Uso de JAZ5a para mejorar la resistencia a la sequía en una planta | |
CY1116646T1 (el) | Αντικαρκινικη πρωτεϊνη συντηξης | |
ES2682981T3 (es) | Proteínas de hemaglutinina del virus de la gripe y método de uso de las mismas | |
CY1117335T1 (el) | Εμβολιο pcsk9 | |
AR067980A1 (es) | Peptidos de cdh3 y agentes que los comprenden | |
PE20170955A1 (es) | Nuevas proteinas inhibidoras de insectos | |
ES2721400T3 (es) | Composición de Diclofenaco | |
BR112016016103A2 (pt) | Composição de antígenos micobacterianos | |
UY36617A (es) | Proteínas de fusión inmunogénicas para el tratamiento del cáncer | |
CO2017011431A2 (es) | Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina | |
PE20211303A1 (es) | Polipeptidos del factor vii de accion corta |